Jpmorgan Chase & CO Embecta Corp. Transaction History
Jpmorgan Chase & CO
- $1.1 Trillion
- Q1 2024
A detailed history of Jpmorgan Chase & CO transactions in Embecta Corp. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 109,485 shares of EMBC stock, worth $1.37 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
109,485
Previous 76,541
43.04%
Holding current value
$1.37 Million
Previous $1.45 Million
0.28%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EMBC
# of Institutions
392Shares Held
52.2MCall Options Held
45.7KPut Options Held
49K-
Black Rock Inc. New York, NY9.28MShares$116 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.21MShares$90.2 Million0.0% of portfolio
-
River Road Asset Management, LLC3.45MShares$43.1 Million0.63% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.23MShares$40.4 Million0.02% of portfolio
-
American Century Companies Inc Kansas City, MO3.14MShares$39.3 Million0.03% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $723M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...